Rétinéal
Food supplement declared in France, declaration No 2023-9-204
Rétinéal is a food supplement declared in France. Status: retrait du marché annoncé pour le 3 July 2029. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- not provided
- Food business operator placing the product on the market
- Laboratoires DENSMORE
- Status
- Retrait du marché annoncé pour le 3 July 2029
- Form
- Comprimé
- Daily dose
- 1 comprimé
- Directions for use
- 1 comprimé par jour
- Intended populations
- Personnes de plus de 60 ans, Homme, Femme
- Not recommended for (according to the manufacturer)
- Sous anticoagulants
- Objectives stated by the manufacturer (these are not authorised claims)
- Œil / Vision
Declaration 134489, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retrait du marché annoncé pour le 3 July 2029, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Curcuma longa L. | Rhizome | Autre extrait sec | 300 mg |
| Tagetes erecta L. | Parties aériennes | Extrait sec alcoolique | 34.02 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Quercétine | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Bisglycinate de zinc | Zinc | 25 mg | 15 mg |
Additives
E460, E341, E470b, E463, E553b, E170, E101, E464
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
L'emploi chez les personnes sous anticoagulant, anticancéreux et immunosuppresseurs et souffrant de pathologies de voies biliaires est déconseillé.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.